Related Experiment Video
Updated: May 1, 2026
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
IKKα restoration via EZH2 suppression induces nasopharyngeal carcinoma differentiation
11] Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China [2].
Abstract:
Lack of cellular differentiation is a key feature of nasopharyngeal carcinoma (NPC), but it also presents as a unique opportunity for intervention by differentiation therapy. Here using RNA-seq profiling analysis and functional assays, we demonstrate that reduced IKKα expression is responsible for the undifferentiated phenotype of NPC. Conversely, overexpression of IKKα induces differentiation and reduces tumorigenicity of NPC cells without activating NF-κB signalling. Importantly, we describe a mechanism whereby EZH2 directs IKKα transcriptional repression via H3K27 histone methylation on the IKKα promoter. The differentiation agent, retinoic acid, increases IKKα expression by suppressing EZH2-mediated H3K27 histone methylation, resulting in enhanced differentiation of NPC cells. In agreement, an inverse correlation between IKKα (low) and EZH2 (high) expression is associated with a lack of differentiation in NPC patient samples. Collectively, these findings demonstrate a role for IKKα in NPC differentiation and reveal an epigenetic mechanism for IKKα regulation, unveiling a new avenue for differentiation therapy.
Insights
Reduced IKKα expression drives nasopharyngeal carcinoma (NPC) undifferentiation. Restoring IKKα via retinoic acid promotes NPC cell differentiation by overcoming EZH2-mediated epigenetic repression, offering a new therapeutic strategy.
Area of Science:
- Oncology
- Epigenetics
- Cellular Differentiation
Background:
- Nasopharyngeal carcinoma (NPC) is characterized by a lack of cellular differentiation.
- This undifferentiated state presents a potential target for differentiation therapy.
Purpose of the Study:
- To investigate the role of IKKα in NPC differentiation.
- To elucidate the epigenetic mechanism regulating IKKα expression in NPC.
- To explore retinoic acid as a differentiation agent for NPC.
Main Methods:
- RNA-sequencing (RNA-seq) profiling and functional assays were employed.
- Investigated the mechanism of IKKα transcriptional repression by EZH2 via H3K27 histone methylation.
- Assessed the effect of retinoic acid on IKKα expression and NPC cell differentiation.
Main Results:
- Reduced IKKα expression was identified as the cause of the undifferentiated NPC phenotype.
- Overexpression of IKKα induced NPC cell differentiation and reduced tumorigenicity without activating NF-κB signaling.
- EZH2 was found to repress IKKα transcription through H3K27 methylation; retinoic acid suppressed this methylation, increasing IKKα and promoting differentiation.
- Low IKKα and high EZH2 expression correlated with poor differentiation in NPC patient samples.
Conclusions:
- IKKα plays a crucial role in NPC differentiation.
- An epigenetic mechanism involving EZH2 and H3K27 methylation regulates IKKα expression.
- This study reveals a novel therapeutic avenue for NPC differentiation therapy using retinoic acid.
More Related Videos
10:26Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019